Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: | Pemetrexed Dr. Reddy’s |
Active Ingredient: | Pemetrexed disodium 551.4mg equivalent to pemetrexed 500mg |
Dosage Form: | Powder for infusion |
New Zealand Sponsor: | Dr Reddy’s New Zealand Limited |
Manufacturer: | Dr Reddy’s Laboratories Limited, Visakhapatnam, India |
Product: | Rinvoq |
Active Ingredient: | Upadacitinib hemihydrate 46.1mg equivalent to upadacitinib 45mg |
Dosage Form: | Modified release tablet |
New Zealand Sponsor: | AbbVie Limited |
Manufacturer: | AbbVie Ireland NL B.V., Sligo, Ireland |
Dated this 23rd day of June 2023.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).